Access cutting-edge spinal cord injuries (sci) treatment through this early phase 1 clinical trial at a research site in Washington D.C.. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Washington D.C. location
Preparing your pre-screening questions…
Access spinal cord injuries (sci) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related spinal cord injuries (sci) treatment provided free
Check if you qualify for this spinal cord injuries (sci) clinical trial in Washington D.C., DC
No-Cost Study Care
Local to Washington D.C.
Convenient for DC residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this clinical trial is to determine whether Lactobacillus crispatus strains isolated from the lower urinary tracts of adult women can be used as an antibiotic-sparing treatment for urinary symptoms and urinary tract infection (UTI) among adults with neurogenic lower urinary tract dysfunction (NLUTD). The main question\[s\] it aims to answer are: 1. To identify soluble bactericidal compounds produced by urinary isolates of L. crispatus that kill uropathogenic E. coli (UPEC). 2. To determine if intravesical instillation of L. crispatus is safe and well tolerated in adults with NLUTD due to SCI who use intermittent catheterization (IC). If there is a comparison group: Researchers will compare L. Crispatus to standard care saline to see if there is a difference in urinary symptoms and urinary microbiome. Participants will be asked to complete daily symptom surveys, complete 2 bladder instillations, and collect, freeze, and return 14 urine samples.
Sponsor: Medstar Health Research Institute
Yes, this clinical trial (NCT07308808) has an active research site in Washington D.C., DC that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for spinal cord injuries (sci) treatment options in Washington D.C., DC, this clinical trial (NCT07308808) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington D.C. research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced spinal cord injuries (sci) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all spinal cord injuries (sci) clinical trials near you to find additional studies recruiting in your area.
See all spinal cord injury clinical trials recruiting in Washington D.C. — not just this study.
Browse Spinal Cord Injury Trials in Washington D.C. →